José Pablo Leone

2.6k total citations · 1 hit paper
88 papers, 1.3k citations indexed

About

José Pablo Leone is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, José Pablo Leone has authored 88 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 27 papers in Cancer Research. Recurrent topics in José Pablo Leone's work include Brain Metastases and Treatment (25 papers), Breast Cancer Treatment Studies (23 papers) and Male Breast Health Studies (19 papers). José Pablo Leone is often cited by papers focused on Brain Metastases and Treatment (25 papers), Breast Cancer Treatment Studies (23 papers) and Male Breast Health Studies (19 papers). José Pablo Leone collaborates with scholars based in United States, Argentina and Italy. José Pablo Leone's co-authors include Bernardo Amadeo Leone, Julieta Leone, Carlos Vallejo, Vyshak Alva Venur, Nancy U. Lin, Ariel Osvaldo Zwenger, Adam Brufsky, Adrian V. Lee, Rohit Bhargava and Sara M. Tolaney and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

José Pablo Leone

81 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunotherapy in Breast Cancer

2024 47 citations Sara Giordano, José Pablo Leone et al. International Journal of Molecular Sciences profile →

Peers

Countries citing papers authored by José Pablo Leone

Since Specialization

Citations

This map shows the geographic impact of José Pablo Leone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Pablo Leone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Pablo Leone more than expected).

Fields of papers citing papers by José Pablo Leone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Pablo Leone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Pablo Leone. The network helps show where José Pablo Leone may publish in the future.

Co-authorship network of co-authors of José Pablo Leone

This figure shows the co-authorship network connecting the top 25 collaborators of José Pablo Leone. A scholar is included among the top collaborators of José Pablo Leone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Pablo Leone. José Pablo Leone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unveiling the paradigm shift: systemic treatment strategies in small, node-negative breast cancer 2025 ·npj Breast Cancer ·(unknown), Mariana Scaranti, (unknown), Renata Colombo Bonadio, Romualdo Barroso‐Sousa, José Pablo Leone	0
2	Survival outcomes and treatment patterns by tumor subtype (TS) in stage III inflammatory and non-inflammatory breast cancer (BC). 2024 ·Journal of Clinical Oncology ·José Pablo Leone, Julieta Leone, Faina Nakhlis, Ilana Schlam, Kelly A. Hirko, Aditi Hazra, Jennifer R. Bellon, Carlos Vallejo, Nancy U. Lin, Sara M. Tolaney, Filipa Lynce	1
3	Immunotherapy in Breast Cancer breakdown → 2024 ·International Journal of Molecular Sciences ·(unknown), Sara Giordano, José Pablo Leone	47
4	A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer 2024 ·Clinical Cancer Research ·(unknown), Priya Kumthekar, Qingchun Jin, (unknown), (unknown), (unknown), José Pablo Leone, Elizabeth A. Mittendorf, (unknown), (unknown), (unknown), (unknown), Nabihah Tayob, Erica L. Mayer, Eric P. Winer, Sara M. Tolaney, Nancy U. Lin	2
5	Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes 2024 ·Breast Cancer Research ·(unknown), (unknown), Allison Clark, Mehrad Tavallai, Dexter X. Jin, Ethan Sokol, Kimberly McGregor, Jeffrey S. Ross, Natalie Danziger, José Pablo Leone	2
6	Estimating mortality in women with triple-negative breast cancer: The ‘ESTIMATE triple-negative’ tool 2023 ·European Journal of Cancer ·José Pablo Leone, (unknown), Noah Graham, (unknown), (unknown), Sara M. Tolaney, Bernardo Amadeo Leone, Rachel A. Freedman, Michael J. Hassett, Carlos Vallejo, Eric P. Winer, Nancy U. Lin, Nabihah Tayob	2
7	Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective 2022 ·Dove Medical Press (Taylor and Francis Group) ·(unknown), (unknown), José Pablo Leone	27
8	Male Breast Cancer: An Updated Review of Epidemiology, Clinicopathology, and Treatment 2022 ·Journal of Oncology ·(unknown), José Pablo Leone	27
9	Advances in the Management of Central Nervous System Metastases from Breast Cancer 2022 ·International Journal of Molecular Sciences ·(unknown), José Pablo Leone	4
10	Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool 2022 ·European Journal of Cancer ·José Pablo Leone, (unknown), Noah Graham, Sara M. Tolaney, Bernardo Amadeo Leone, Rachel A. Freedman, Michael J. Hassett, Julieta Leone, Carlos Vallejo, Eric P. Winer, Nancy U. Lin, Nabihah Tayob	4
11	Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry 2021 ·Breast Cancer Research and Treatment ·José Pablo Leone, Bernardo Amadeo Leone, Nabihah Tayob, Michael J. Hassett, Julieta Leone, Rachel A. Freedman, Sara M. Tolaney, Eric P. Winer, Carlos Vallejo, Nancy U. Lin	9
12	A practical guide to endocrine therapy in the management of estrogen receptor-positive male breast cancer 2021 ·SHILAP Revista de lepidopterología ·Siddhartha Yadav, Karthik V. Giridhar, José Pablo Leone, Roberto A. Leon‐Ferre, Kathryn J. Ruddy	4
13	Factors associated with late risks of breast cancer-specific mortality in the SEER registry 2021 ·Breast Cancer Research and Treatment ·José Pablo Leone, Carlos Vallejo, Michael J. Hassett, Julieta Leone, Noah Graham, Nabihah Tayob, Rachel A. Freedman, Sara M. Tolaney, Bernardo Amadeo Leone, Eric P. Winer, Nancy U. Lin	16
14	Tumor subtypes and survival in male breast cancer 2021 ·Breast Cancer Research and Treatment ·Julieta Leone, Rachel A. Freedman, Nancy U. Lin, Sara M. Tolaney, Carlos Vallejo, Bernardo Amadeo Leone, Eric P. Winer, José Pablo Leone	22
15	Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry 2021 ·Breast Cancer Research and Treatment ·José Pablo Leone, Carlos Vallejo, Michael J. Hassett, Julieta Leone, Noah Graham, Nabihah Tayob, Rachel A. Freedman, Sara M. Tolaney, Bernardo Amadeo Leone, Eric P. Winer, Nancy U. Lin	2
16	Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial 2020 ·Cancer ·José Pablo Leone, Bernard F. Cole, Meredith M. Regan, Beat Thürlimann, Alan S. Coates, Manuela Rabaglio, Anita Giobbie‐Hurder, Richard D. Gelber, Bent Ejlertsen, Vernon Harvey, Patrick Neven, István Láng, Hervé Bonnefoi, Andrew Wardley, Aron Goldhirsch, Angelo Di Leo, Marco Colleoni, Inês Vaz-Luís, Nancy U. Lin	5
17	Perceptions of patients with early stage breast cancer toward research biopsies 2020 ·Cancer ·Davinia Seah, José Pablo Leone, Thomas H. Openshaw, (unknown), Nabihah Tayob, Jiani Hu, Ruth Lederman, Elizabeth S. Frank, Jessica Sohl, Zsofia K. Stadler, (unknown), Stuart G. Silverman, Jeffrey Peppercorn, Eric P. Winer, Steven E. Come, Nancy U. Lin	3
18	Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer 2018 ·Molecular Cancer Research ·Ahmed Basudan, Nolan Priedigkeit, Ryan J. Hartmaier, Ethan S. Sokol, Amir Bahreini, Rebecca Watters, M.M. Boisen, Rohit Bhargava, Kurt R. Weiss, Maria Margarete Karsten, Carsten Denkert, Jens‐Uwe Blohmer, José Pablo Leone, Ronald L. Hamilton, Adam Brufsky, Esther Elishaev, Peter C. Lucas, Adrian V. Lee, Steffi Oesterreich	24
19	Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases 2016 ·JAMA Oncology ·Nolan Priedigkeit, Ryan J. Hartmaier, Yijing Chen, Damir Varešlija, Ahmed Basudan, Rebecca Watters, Roby Thomas, José Pablo Leone, Peter C. Lucas, Rohit Bhargava, Ronald L. Hamilton, Juliann Chmielecki, Shannon L. Puhalla, Nancy E. Davidson, Steffi Oesterreich, Adam Brufsky, Leonie S. Young, Adrian V. Lee	118
20	Prognostic significance of tumor subtypes in male breast cancer: a population-based study 2015 ·Breast Cancer Research and Treatment ·José Pablo Leone, Julieta Leone, Ariel Osvaldo Zwenger, (unknown), Carlos Vallejo, Bernardo Amadeo Leone	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact